Who backs Atalanta Therapeutics?
11 investors| Investor | Type |
|---|---|
| F-Prime Capital | Venture capital |
| Mirae Asset Capital | Venture capital |
| EQT Life Sciences | Venture capital |
| Novartis Venture Fund | Other |
| Pictet | Other |
| GHR Foundation | Other |
| Aberdeen Investments (Scotland) | — |
| Biogen | — |
| Genentech | — |
| RiverVest Venture Partners | — |
| + 1 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Atalanta Therapeutics investors
11 investors are on record for Atalanta Therapeutics, including F-Prime Capital, Mirae Asset Capital, EQT Life Sciences and Novartis Venture Fund.
Free account
More of Atalanta Therapeutics with a free account
- ·The complete investor list: 11 names
- ·Watch Atalanta Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 11 firms already write checks for companies like Atalanta Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View